General Court (President of the Chamber) 1 September 2023, T-393/23 R (Teva GmbH v European Commission.)

ORDER OF THE PRESIDENT OF THE GENERAL COURT 1 September 2023 (*) (Interim relief – Medicinal products for human use – Marketing authorisation – Application for interim measures – Lack of urgency) In Case T‑393/23 R, Teva GmbH, established in Ulm (Germany), represented by Z. West and G. Morgan, Solicitors, and by S. Love, Barrister, applicant, v European Commission, represented by E. Mathieu and A.